Arcellx Inc
Arcellx, Inc., together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States. The company's lead ddCAR product candidate is anitocabtagene autoleucel, which is in phase 2 clinical trial for the treatment of patients with relapsed or refractory multiple myeloma (rrMM). It also develops ACLX-001, a prod… Read more
Arcellx Inc (ACLX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.112x
Based on the latest financial reports, Arcellx Inc (ACLX) has a cash flow conversion efficiency ratio of -0.112x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-49.21 Million) by net assets ($440.78 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Arcellx Inc - Cash Flow Conversion Efficiency Trend (2018–2024)
This chart illustrates how Arcellx Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Arcellx Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Arcellx Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Golar LNG Ltd.
LSE:0HDY
|
0.048x |
|
HUT 8 CORP. O.N.
F:V71
|
N/A |
|
United Spirits Limited
NSE:MCDOWELL-N
|
0.112x |
|
MYR Group Inc
NASDAQ:MYRG
|
0.174x |
|
FASTIG.AB BALD. B SK 016
F:28F0
|
N/A |
|
Brunello Cucinelli S.p.A
OTCGREY:BCUCF
|
0.079x |
|
APL Apollo Tubes Limited
NSE:APLAPOLLO
|
0.039x |
|
Temenos AG
PINK:TMNSF
|
0.473x |
Annual Cash Flow Conversion Efficiency for Arcellx Inc (2018–2024)
The table below shows the annual cash flow conversion efficiency of Arcellx Inc from 2018 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $454.79 Million | $-83.47 Million | -0.184x | -142.92% |
| 2023-12-31 | $485.38 Million | $207.57 Million | 0.428x | +188.26% |
| 2022-12-31 | $204.95 Million | $-99.30 Million | -0.485x | -208.55% |
| 2021-12-31 | $-121.52 Million | $-54.24 Million | 0.446x | +178.71% |
| 2020-12-31 | $50.54 Million | $-28.66 Million | -0.567x | -198.90% |
| 2019-12-31 | $-32.74 Million | $-18.77 Million | 0.573x | +216.97% |
| 2018-12-31 | $14.00 Million | $-6.86 Million | -0.490x | -- |